While the Canadian stock market, like any other, efficiently reflects intrinsic value in share prices over the long term, it often gets it wrong in the short term, predominantly with undercovered small-cap stocks, underpricing assets too early in their development for most investors to buy into despite the exponential nature of their potential.
Today’s Weekly Market Movers covers three attractive names to put this contrarian investment thesis in play, each of them marked by assets and operations that seem destined for far more than their stock prices suggest, granting investors strong long-term chances at realizing considerable upside.
Theralase Technologies
Theralase Technologies, market capitalization C$45.47 million, is a clinical-stage pharmaceutical company researching and developing light, radiation, sound and/or drug-activated small-molecule compounds, their associated drug formulations and the light…
